Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone.

导出 OA

翻译打印收藏纠错

作者： Liancheng,Fan ^[1] ; Chenfei,Chi ^[1] ; Sanwei,Guo ^[2] ; Yanqing,Wang ^[1] ; Wen,Cai ^[1] ; Xiaoguang,Shao ^[1] ; Fan,Xu ^[1] ; Jiahua,Pan ^[1] ; Yinjie,Zhu ^[1] ; Xun,Shangguan ^[1] ; Zhixiang,Xin ^[1] ; Jianian,Hu ^[1] ; Hongyang,Qian ^[1] ; Shaowei,Xie ^[1] ; Rui,Wang ^[3] ; Lixin,Zhou ^[1] ; Baijun,Dong ^[1] ; Wei,Xue ^[1]

作者单位： Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127,China. ^[1] Department of Urology, Shanghai International Medical Center, No.4358 KangXin Awy, Shanghai 200000,China. ^[2] Shanghai Institute of Ultrasound in Medicine, Department of Ultrasonography, Shanghai Jiaotong University Affiliated No. 6 Hospital, Yishan Road 600, Shanghai 200233, PR China. ^[3]

关键词 Metastatic castration-resistant prostate cancer abiraterone acetate nutrition pre-albumin.prognostic model

DOI 10.7150/jca.21134

PMID 29151928

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交